During the last session, 908 Devices Inc (NASDAQ:MASS)’s traded shares were 0.37 million, with the beta value of the company hitting 1.04. At the end of the trading day, the stock’s price was $2.61, reflecting an intraday loss of -6.12% or -$0.17. The 52-week high for the MASS share is $8.50, that puts it down -225.67 from that peak though still a striking 30.65% gain since the share price plummeted to a 52-week low of $1.81. The company’s market capitalization is $90.89M, and the average intraday trading volume over the past 10 days was 2.01 million shares, and the average trade volume was 622.37K shares over the past three months.
908 Devices Inc (MASS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.40. MASS has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.35.
908 Devices Inc (NASDAQ:MASS) trade information
908 Devices Inc (MASS) registered a -6.12% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.12% in intraday trading to $2.61, hitting a weekly high. The stock’s 5-day price performance is -10.00%, and it has moved by 26.70% in 30 days. Based on these gigs, the overall price performance for the year is -68.33%. The short interest in 908 Devices Inc (NASDAQ:MASS) is 1.65 million shares and it means that shorts have 4.42 day(s) to cover.
908 Devices Inc (MASS) estimates and forecasts
Statistics show that 908 Devices Inc has underperformed its competitors in share price, compared to the industry in which it operates. 908 Devices Inc (MASS) shares have gone down -51.49% during the last six months, with a year-to-date growth rate less than the industry average at -76.11% against 14.40. In the rating firms’ projections, revenue will increase 14.38% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 17M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 13.44M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 14.35M and 9.99M respectively. In this case, analysts expect current quarter sales to grow by 18.47% and then jump by 34.52% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -31.19%. While earnings are projected to return -48.32% in 2025, the next five years will return -0.59% per annum.
MASS Dividends
908 Devices Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
908 Devices Inc (NASDAQ:MASS)’s Major holders
908 Devices Inc insiders own 8.20% of total outstanding shares while institutional holders control 69.71%, with the float percentage being 75.94%. ARK INVESTMENT MANAGEMENT LLC is the largest shareholder of the company, while 122.0 institutions own stock in it. As of 2024-06-30, the company held over 3.94 million shares (or 12.0377% of all shares), a total value of $20.28 million in shares.
The next largest institutional holding, with 1.88 million shares, is of AMERIPRISE FINANCIAL INC’s that is approximately 5.7552% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $9.7 million.
Also, the Mutual Funds coming in first place with the largest holdings of 908 Devices Inc (MASS) shares are ARK ETF Tr-ARK Genomic Revolution ETF and Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I . Data provided on Nov 30, 2024 indicates that ARK ETF Tr-ARK Genomic Revolution ETF owns about 3.0 shares. This amounts to just over 8.61 percent of the company’s overall shares, with a $7.83 million market value. The same data shows that the other fund manager holds slightly less at 1.51, or about 4.33% of the stock, which is worth about $3.94 million.
